相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers
Brian S. Gloss et al.
CANCER LETTERS (2012)
A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment
Hagen Kulbe et al.
CANCER RESEARCH (2012)
The Changing View of High-Grade Serous Ovarian Cancer
Els M. J. J. Berns et al.
CANCER RESEARCH (2012)
DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination
Christopher Korch et al.
GYNECOLOGIC ONCOLOGY (2012)
The peritoneal tumour microenvironment of high-grade serous ovarian cancer
D. Andrew Leinster et al.
JOURNAL OF PATHOLOGY (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
BRCAness: Finding the Achilles Heel in Ovarian Cancer
Georgios Rigakos et al.
ONCOLOGIST (2012)
Dissecting PI3Kness: The Complexity of Personalized Therapy for Ovarian Cancer
Robert C. Bast et al.
CANCER DISCOVERY (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
Jermaine Coward et al.
CLINICAL CANCER RESEARCH (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Integrative genomics viewer
James T. Robinson et al.
NATURE BIOTECHNOLOGY (2011)
Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
Jean-Pierre Gillet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan et al.
NATURE REVIEWS CANCER (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Activation of Phosphatidylcholine Cycle Enzymes in Human Epithelial Ovarian Cancer Cells
Egidio Iorio et al.
CANCER RESEARCH (2010)
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
Ashour Ahmed Ahmed et al.
JOURNAL OF PATHOLOGY (2010)
A global map of human gene expression
Margus Lukk et al.
NATURE BIOTECHNOLOGY (2010)
Researchers find a new cancer gene and a possible link between ovarian cancer and endometriosis
[Anonymous]
WOMENS HEALTH (2010)
Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma
S. L. Cooke et al.
ONCOGENE (2010)
The genesis and evolution of high-grade serous ovarian cancer
David D. L. Bowtell
NATURE REVIEWS CANCER (2010)
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Kimberly C. Wiegand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Ovarian Low-grade and High-grade Serous Carcinoma Pathogenesis, Clinicopathologic and Molecular Biologic Features, and Diagnostic Problems
Russell Vang et al.
ADVANCES IN ANATOMIC PATHOLOGY (2009)
Ovarian Cancer
Kathleen R. Cho et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
PIK3CA cooperates with other phosphatidylinositol 3′-kinase pathway mutations to effect oncogenic transformation
Katsutoshi Oda et al.
CANCER RESEARCH (2008)
Combining the farnesyltransferase inhibitor lonafarnib with paclitaxel results in enhanced growth inhibitory effects on human ovarian cancer models in vitro and in vivo
Stacey A. Taylor et al.
GYNECOLOGIC ONCOLOGY (2008)
Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma
C. Blake Gilks et al.
HUMAN PATHOLOGY (2008)
Alternate molecular genetic pathways in ovarian carcinomas of common histological types
Julia Willner et al.
HUMAN PATHOLOGY (2007)
Pathway-specific differences between tumor cell lines and normal and tumor tissue cells
Adam Ertel et al.
MOLECULAR CANCER (2006)
M-cam expression as marker of poor prognosis in epithelial ovarian cancer
Daniela Aldovini et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary
David M. Gershenson et al.
OBSTETRICS AND GYNECOLOGY (2006)
Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness
Paul P. Szotek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Comparative analysis and integrative classification of NC160 cell lines and primary tumors using gene expression profiling data
Huixia Wang et al.
BMC GENOMICS (2006)
Comparative analysis and integrative classification of NCI60 cell lines and primary tumors using gene expression profiling data
Huixia Wang et al.
BMC GENOMICS (2006)
Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma
P Macor et al.
CANCER RESEARCH (2006)
High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma
K Oda et al.
CANCER RESEARCH (2005)
Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI)
R Sandberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Serial Analysis of Gene Expression (SAGE) database analysis of chemosensitivity: Comparing solid tumors with cell lines and comparing solid tumors from different tissue origins
WD Stein et al.
CANCER RESEARCH (2004)
In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours
NLG Sieben et al.
JOURNAL OF PATHOLOGY (2004)
CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma
D Mezzanzanica et al.
CLINICAL CANCER RESEARCH (2004)
Comparison of established cell lines at different passages by karyotype and comparative genomic hybridization
SL Wenger et al.
BIOSCIENCE REPORTS (2004)
Microsatellite instability and expression of hMLH1 and hMSH2 proteins in ovarian endometrioid cancer
JS Liu et al.
MODERN PATHOLOGY (2004)
Mutation of the PIK3CA gene in ovarian and breast cancer
IG Campbell et al.
CANCER RESEARCH (2004)
Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2
L De Cecco et al.
ONCOGENE (2004)
The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin
JD Seidman et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2004)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma
G Singer et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Exon 3 of the α folate receptor gene contains a 5′ splice site which confers enhanced ovarian carcinoma specific expression
E Galmozzi et al.
FEBS LETTERS (2001)
分享论文
